Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

payer survey

- PMLiVE

New thinking, bold action: building a better future for people living with severe diseases

How UCB Neurology’s deep understanding of people living with neurological conditions is transforming the patient journey

Day in a #LucidLife – Meet Philippa

Ever wondered what a #LucidLife looks like?Philippa McClure, Senior Account Director, takes us through her day. We have a number of roles in client services, just like Philippa's.So, if you like what...

Lucid Group Communications Limited

- PMLiVE

Sanofi, Regeneron’s Libtayo shows marked reduction in risk of death in cervical cancer patients

Phase 3 trial showed drug reduced the risk of death by 31% compared to chemotherapy

- PMLiVE

WHO backs emergency use of J&J’s one-dose COVID-19 vaccine

Vaccine is already approved for emergency use by the European Commission and the FDA

- PMLiVE

Safety review shows ‘no evidence’ that AZ’s vaccine causes increased risk of blood clots

AZ's vaccine continues to be backed by the EMA and the EMA’s Pharmacovigilance Risk Assessment Committee

- PMLiVE

bluebird bio reveals long-term data for Lenti-D gene therapy in CALD

At 24 months of follow-up, 90% of patients were free of major functional disabilities

- PMLiVE

McCann Health appoints Adriano Botter as global chief digital officer

Botter previously served as digital director for McCann Health Brazil

- PMLiVE

Could the rare disease community teach pharma a lesson?

by Leigh Ansell

CRYOPORT APPOINTS MIND+MATTER AS PART OF A GLOBAL BRAND DEVELOPMENT TENDER

Cryoport Inc has appointed creative communications agency Mind+Matter, an Ashfield Health company, part of UDG Healthcare as its strategic marketing partner to support the rebrand of the entire business alongside...

Inizio

- PMLiVE

Novavax COVID-19 vaccine found to be 86% effective against UK variant

Phase 2b trial also finds vaccine efficacy of 55.4% against South Africa variant

- PMLiVE

Red Havas Health launch unites health professionals from across the globe

Red Havas has announced the launch of Red Havas Health

- PMLiVE

FDA advisory committee to review oncology accelerated approvals

Review comes after voluntary indication withdrawals for a number of cancer therapies

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links